MODITOPE Trademark
Trademark Overview
On Friday, July 28, 2023, a trademark application was filed for MODITOPE with the United States Patent and Trademark Office. The USPTO has given the MODITOPE trademark a serial number of 98107336. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, November 26, 2024. This trademark is owned by Scancell Limited. The MODITOPE trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, namely, for the treatment of cancer; therapeutic preparations and substances, namely, for the treatment of cancer; chemical preparations, namely, for the treatment of cancer; diagnostic reagents for medical use; DNA, antibodies and proteins that stimulate high-avidity T-cells responses for therapeutic and medical use, namely, for the treatment of cancer; pharmaceutical compounds for treatment of cancer; vaccine preparations and substances; peptide vaccines; DNA vaccines and substances
General Information
| Serial Number | 98107336 |
| Word Mark | MODITOPE |
| Filing Date | Friday, July 28, 2023 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, November 26, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 26, 2024 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations, namely, for the treatment of cancer; therapeutic preparations and substances, namely, for the treatment of cancer; chemical preparations, namely, for the treatment of cancer; diagnostic reagents for medical use; DNA, antibodies and proteins that stimulate high-avidity T-cells responses for therapeutic and medical use, namely, for the treatment of cancer; pharmaceutical compounds for treatment of cancer; vaccine preparations and substances; peptide vaccines; DNA vaccines and substances |
| Translation of Words in Mark | The word MODITOPE has no meaning in a foreign language. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 28, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Scancell Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Oxford OX44GD
GB |
| Party Name | Scancell Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Oxford OX44GD
GB |
Trademark Events
| Event Date | Event Description |
| Tuesday, August 1, 2023 | NEW APPLICATION ENTERED |
| Monday, August 28, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, March 29, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, April 17, 2024 | PRIORITY ACTION WRITTEN |
| Wednesday, April 17, 2024 | PRIORITY ACTION E-MAILED |
| Wednesday, April 17, 2024 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Monday, June 24, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, October 9, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, October 9, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, October 9, 2024 | ASSIGNED TO LIE |
| Saturday, November 2, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 20, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 26, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 26, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
